FDA Inspection 1271571 - Bell Pharmaceuticals, Inc - June 18, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bell Pharmaceuticals, Inc

Record Details

This FDA Inspection record concerns Bell Pharmaceuticals, Inc, with an inspection on June 18, 2025, issued by the Minneapolis District Office, covering human drugs.

Company: Bell Pharmaceuticals, Inc
Inspection Date: June 18, 2025
Product Type: Human Drugs
Office: Minneapolis District Office

Open in Dashboard

ID · 1926ee2f-7dde-4b69-842d-0d7262eb1ed9

Violation Codes7

21 CFR 211.100(a)21 CFR 211.10321 CFR 211.160(b)21 CFR 211.19221 CFR 211.22(a)21 CFR 211.6321 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.